Cargando…

A viral insulin-like peptide is a natural competitive antagonist of the human IGF-1 receptor

OBJECTIVE: Natural sources of molecular diversity remain of utmost importance as a reservoir of proteins and peptides with unique biological functions. We recently identified such a family of viral insulin-like peptides (VILPs). We sought to advance the chemical methods in synthesis to explore the s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Fa, Altindis, Emrah, Kahn, C. Ronald, DiMarchi, Richard D., Gelfanov, Vasily
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621328/ https://www.ncbi.nlm.nih.gov/pubmed/34400347 http://dx.doi.org/10.1016/j.molmet.2021.101316

Ejemplares similares

Interaction of a viral insulin-like peptide with the IGF-1 receptor produces a natural antagonist
por: Moreau, Francois, et al.
Publicado: (2022)

Characterization of Viral Insulin-Like Peptides Reveals Unique White Adipose Tissue Specific Characteristics
por: Chrudinova, Martina, et al.
Publicado: (2021)

A glucagon analog chemically stabilized for immediate treatment of life-threatening hypoglycemia()
por: Chabenne, Joseph, et al.
Publicado: (2014)

Efficacy of glucagon-like peptide-1 and estrogen dual agonist in pancreatic islets protection and pre-clinical models of insulin-deficient diabetes
por: Fuselier, Taylor, et al.
Publicado: (2022)

Effect of targeted estrogen delivery using glucagon-like peptide-1 on insulin secretion, insulin sensitivity and glucose homeostasis
por: Tiano, Joseph P., et al.
Publicado: (2015)

Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism
por: Mroz, Piotr A., et al.
Publicado: (2018)

Characterization of viral insulins reveals white adipose tissue-specific effects in mice
por: Chrudinová, Martina, et al.
Publicado: (2020)

Viruses and Metabolism: The Effects of Viral Infections and Viral Insulins on Host Metabolism
por: Girdhar, Khyati, et al.
Publicado: (2021)

Smarter Modeling to Enable a Smarter Insulin
por: Taylor, Simeon I., et al.
Publicado: (2020)

Discovery of a potent GIPR peptide antagonist that is effective in rodent and human systems
por: Yang, Bin, et al.
Publicado: (2022)

Insulin-like and IGF-like peptides in the silkmoth Bombyx mori: discovery, structure, secretion, and function
por: Mizoguchi, Akira, et al.
Publicado: (2013)

Understanding the Mechanism of Insulin and Insulin-Like Growth Factor (IGF) Receptor Activation by IGF-II
por: Alvino, Clair L., et al.
Publicado: (2011)

Insulin-Like Growth Factor-I E-Peptide Activity Is Dependent on the IGF-I Receptor
por: Brisson, Becky K., et al.
Publicado: (2012)

Tissue differences in the exosomal/small extracellular vesicle proteome and their potential as indicators of altered tissue metabolism
por: Garcia-Martin, Ruben, et al.
Publicado: (2022)

Competitive binding of antagonistic peptides fine-tunes stomatal patterning
por: Lee, Jin Suk, et al.
Publicado: (2015)

vPIF-1 is an insulin-like antiferroptotic viral peptide
por: Belavgeni, Alexia, et al.
Publicado: (2023)

A gut microbial peptide and molecular mimicry in the pathogenesis of type 1 diabetes
por: Girdhar, Khyati, et al.
Publicado: (2022)

Peptide Conjugates with Small Molecules Designed to Enhance Efficacy and Safety
por: He, Rongjun, et al.
Publicado: (2019)

Homozygous receptors for insulin and not IGF-1 accelerate intimal hyperplasia in insulin resistance and diabetes
por: Li, Qian, et al.
Publicado: (2019)

Identification of insulin-like growth factor (IGF)-I and IGF-binding protein in chylous ascites.
por: Lee, D. Y.
Publicado: (1998)

Insulin-like growth factor (IGF)-I and IGF binding proteins axis in diabetes mellitus
por: Kim, Min Sun, et al.
Publicado: (2015)

Associations among IGF-1, IGF2, IGF-1R, IGF-2R, IGFBP-3, insulin genetic polymorphisms and central precocious puberty in girls
por: Chang, Hua-Pin, et al.
Publicado: (2018)

Gαs regulates Glucagon-Like Peptide 1 Receptor-mediated cyclic AMP generation at Rab5 endosomal compartment
por: Girada, Shravan Babu, et al.
Publicado: (2017)

The endosymbiont Wolbachia increases insulin/IGF-like signalling in Drosophila
por: Ikeya, Tomoatsu, et al.
Publicado: (2009)

Insulin-Like Growth Factor (IGF) System in Liver Diseases
por: Adamek, Agnieszka, et al.
Publicado: (2018)

Insulin-like Growth Factor-2 (IGF-2) in Fibrosis
por: Zhu, Yuhan, et al.
Publicado: (2022)

Differential Roles of Insulin and IGF-1 Receptors in Adipose Tissue Development and Function
por: Boucher, Jeremie, et al.
Publicado: (2016)

Serum insulin-like growth factor (IGF)-I and IGF-binding proteins in lung cancer patients.
por: Lee, D. Y., et al.
Publicado: (1999)

Immunolocalization of insulin-like growth factor-I (IGF-I) and its receptors (IGF-IR) in the equine epididymis
por: YOON, Minjung, et al.
Publicado: (2014)

Insulin‐like Growth Factor (IGF)‐I, IGF‐binding Protein‐3 and Colorectal Adenomas in Japanese Men
por: Teramukai, Satoshi, et al.
Publicado: (2002)

Insulin growth factor 1 like receptor (IGF-1R)
por: Iyer, Gopal, et al.
Publicado: (2016)

Free Insulin-like Growth Factor (IGF)-I in Children with PWS
por: Damen, Layla, et al.
Publicado: (2022)

The antagonistic pleiotropy of insulin‐like growth factor 1
por: Zhang, William B., et al.
Publicado: (2021)

“Let's Stay Together”; GIP and GLP-1 dual agonism in the treatment of metabolic disease
por: DiMarchi, Richard D.
Publicado: (2018)

Advances in the treatment of metabolic diseases
por: DiMarchi, Richard D.
Publicado: (2021)

Antagonistic regulation by insulin-like peptide and activin ensures the elaboration of appropriate dendritic field sizes of amacrine neurons
por: Luo, Jiangnan, et al.
Publicado: (2020)

Arthropod IGF, relaxin and gonadulin, putative orthologs of Drosophila insulin-like peptides 6, 7 and 8, likely originated from an ancient gene triplication
por: Veenstra, Jan A.
Publicado: (2020)

Central insulin‐like growth factor‐1 (IGF‐1) restores whole‐body insulin action in a model of age‐related insulin resistance and IGF‐1 decline
por: Huffman, Derek M., et al.
Publicado: (2015)

Functional characterization of a competitive peptide antagonist of p65 in human macrophage-like cells suggests therapeutic potential for chronic inflammation
por: Srinivasan, Mythily, et al.
Publicado: (2014)

Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer
por: Renehan, A G, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_l6mb029mc9e4mdsrrtsa2dmrrg